A detailed history of Strs Ohio transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Strs Ohio holds 91,200 shares of FULC stock, worth $372,096. This represents 0.0% of its overall portfolio holdings.

Number of Shares
91,200
Holding current value
$372,096
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$3.18 - $9.74 $290,016 - $888,288
91,200 New
91,200 $325,000
Q1 2022

Apr 21, 2022

SELL
$9.96 - $23.65 $9,960 - $23,650
-1,000 Reduced 12.82%
6,800 $160,000
Q3 2021

Oct 22, 2021

BUY
$7.28 - $30.97 $33,488 - $142,462
4,600 Added 143.75%
7,800 $220,000
Q1 2020

Apr 23, 2020

BUY
$9.49 - $21.26 $18,980 - $42,520
2,000 Added 166.67%
3,200 $38,000
Q3 2019

Oct 21, 2019

BUY
$6.64 - $14.89 $7,968 - $17,868
1,200 New
1,200 $7,000

Others Institutions Holding FULC

About Fulcrum Therapeutics, Inc.


  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $212M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.